Covidien

medtronic.com · Minneapolis, United States of America

Covidien was a global healthcare products company that developed, manufactured, and sold medical devices and supplies used in surgical, respiratory, vascular, and patient care settings, serving hospitals and healthcare providers worldwide. It generated revenue through the sale of products such as surgical stapling systems, energy-based surgical devices, patient monitoring equipment, and medical consumables. Covidien was acquired by Medtronic in 2015 and now operates as part of Medtronic’s broader medical technology portfolio.

Revenue
$10.0B
Employees
39,000
Founded
2007
Headquarters
Minneapolis, United States of America

What 18 Arbolus experts think of Covidien

NPS scores are notably high: 7 respondents gave top scores (NPS 10), with the majority above 8. No negative sentiment is present. Renewal intent is affirmative wherever provided, including among higher spenders. Stickiness is substantial, with over 80% of users in the more-than-1-year implementation stage, and only one instance of 'Pilot' or 'Not Sure' stages. Themes include long-term satisfaction and established adoption.Positive

Who reviewed Covidien

Total customers 18 17 current · 1 former
Reviews growth +18 in six months
Seniority of respondents
  • C-Suite 94% (17)
  • Director 6% (1)
Other Analyst C-Suite NPS 9
Other Generalist C-Suite NPS 10
Other Partner C-Suite NPS 9

Employer names and spend open once the report publishes.

Tell us when the Covidien report publishes.

We'll email you once the full customer report is ready, with employer names, spend and every written answer. No account needed.

Notify me

Sentiment

38 Net Promoter Score, from 18 scored reviews
  • Promoters 10
  • Passives 5
  • Detractors 3

Cumulative NPS by month

+0 over 4 months
  • Apr 8
  • May 8
  • Jun 8
  • Jul 8

Net Promoter Score across 1 reviews, accumulated up to each month. Category median 38 across 1 companies.

Written answers and themes publish with the full report.

Renewal intent

Plan to renew 100%
  • Will renew 1
  • Undecided 0
  • Not renewing 0

Plan to renew, by seniority

  • Not specified 100% 1 answer
  • 10/10 Average score from customers who will renew

For people who use Covidien

Do you use Covidien at work?

Share your software review and get matched to paid projects. Arbolus pays you every time a client reads your review.

  • 18 customers of Covidien have already contributed
Share your experience

Takes a few minutes. Your identity stays anonymous.